Earnings History Data for Renalytix AI (RNLX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Renalytix AI

Renalytix AI plc is an artificial intelligence-enabled in vitro diagnostics company. It focuses on optimizing clinical management of kidney disease. Renalytix AI plc is based in NEW YORK.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
14-02-2024	PM		RNLX	Renalytix AI	62.00	-0.09	-0.09	0.00	Renalytix AI GAAP EPS of -$0.09, revenue of $0.7M [2/15/2024 8:56 AM]	0.7640	-0.45 (-36.86%)	0.87	-0.34 (-28.10%)	0.24 - 4.04	1,826,374	6,820,000	387,308
Renalytix AI GAAP EPS of -$0.09, revenue of $0.7M [2/15/2024 8:56 AM]
14-11-2023	PM		RNLX	Renalytix plc	44.33	-0.11	-0.12	-0.14	Renalytix AI GAAP EPS of -$0.11 misses by $0.01, revenue of $0.46M misses by $0.25M [11/14/2023 10:02 AM]	0.5321	-0.32 (-37.27%)	0.75	-0.10 (-11.59%)	0.50 - 4.04	572,994	60,000	16,443
Renalytix AI GAAP EPS of -$0.11 misses by $0.01, revenue of $0.46M misses by $0.25M [11/14/2023 10:02 AM]
28-09-2023	PM		RNLX	Renalytix AI	97.00	-0.10	-0.13	0.00		1.52	-0.44 (-22.45%)	1.75	-0.21 (-10.65%)	1.05 - 4.04	373,415	40,000	13,073
Renalytix files $200M mixed securities shelf [9/28/2023 1:19 PM]
09-06-2023	PM		RNLX	Renalytix plc	99.88	-0.13	-0.13	-0.20		2.06	-0.12 (-5.28%)	2.15	-0.03 (-1.38%)	1.05 - 5.00	217,439	70,000	34,985

30-03-2023	PM	0:00 AM ET (Mar 30)	RNLX	Renalytix plc	158.68	-0.14	-0.15	-0.21	Renalytix AI GAAP EPS of -$0.14 in-line, revenue of $1.2M misses by $0.08M [3/30/2023 7:16 AM]	2.30	-0.02 (-0.87%)	2.36	0.04 (1.72%)	1.05 - 8.50	16,301	60,000	3,607
Renalytix AI GAAP EPS of -$0.14 in-line, revenue of $1.2M misses by $0.08M [3/30/2023 7:16 AM]
30-11-2022	PM	7:00 AM ET (Nov 30)	RNLX	Renalytix plc	58.42	-0.14	-0.14	-0.14	Renalytix AI GAAP EPS of -$0.16, revenue of $0.97M [11/30/2022 7:09 AM]	2.00	0.12 (6.38%)	1.96	0.08 (4.26%)	1.05 - 19.79	114,299	40,000	6,188
Renalytix AI GAAP EPS of -$0.16, revenue of $0.97M [11/30/2022 7:09 AM] Published Real World Evidence Demonstrates KidneyIntelX Improved Clinical Decisions and Outcomes in High-Risk Patients with Early-Stage Diabetic Kidney Disease [Nov-29-22 07:00AM]
30-06-2022	PM	0:00 AM ET (Jun 30)	RNLX	Renalytix AI plc	149.52	-0.20	-0.17	-0.12	Renalytix AI GAAP EPS of -$0.20, revenue of $0.81M [6/30/2022 7:09 AM]	2.44	-1.53 (-38.66%)	2.91	-1.06 (-26.70%)	2.23 - 34.98	1,377,682	80,000	23,604
Renalytix AI GAAP EPS of -$0.20, revenue of $0.81M [6/30/2022 7:09 AM] Renalytix stock touches record low on wider quarterly loss [6/30/2022 11:24 AM] Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2022 [Jun-30-22 07:00AM]
31-03-2022	PM	7:00 AM ET (Mar 31)	RNLX	Renalytix AI plc	212.59	-0.21	-0.17	-0.12	Renalytix AI GAAP EPS of -$0.21 misses by $0.04, revenue of $0.84M misses by $0.21M [3/31/2022 7:05 AM]	6.90	-0.23 (-3.23%)	8.45	1.32 (18.51%)	5.78 - 35.71	280,953	110,000	17,018
Renalytix AI GAAP EPS of -$0.21 misses by $0.04, revenue of $0.84M misses by $0.21M [3/31/2022 7:05 AM] Renalytix surges on launching $30M financing package [3/31/2022 7:55 AM] Confirmation of Appointment of Timothy Scannell to Renalytix Board of Directors [Mar-30-22 07:00AM] Renalytix announces a $30.0 million financing package [Mar-31-22 07:05AM] Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2022 [Mar-31-22 07:00AM]
07-12-2021	PM	7:00 AM ET (Dec 7)	RNLX	Renalytix AI plc	590.40	-0.14	-0.14	-0.10	Renalytix AI EPS in-line, misses on revenue [12/7/2021 7:13 AM]	15.38	0.39 (2.60%)	15.00	0.01 (0.07%)	11.85 - 35.71	287,385	110,000	1,144
Renalytix AI EPS in-line, misses on revenue [12/7/2021 7:13 AM]
21-10-2021	PM	0:00 AM ET (Oct 21)	RNLX	Renalytix AI PLC Sponsored ADR	882.00	-0.08	-0.18	0.00		27.15	1.20 (4.62%)	26.26	0.31 (1.19%)	10.31 - 35.71	159,812	70,000	3,047
Renalytix AI reports FY results [10/21/2021 7:30 AM] Renalytix Reports Full Year Fiscal 2021 Results [Oct-21-21 07:00AM]
15-06-2021	PM		RNLX	Renalytix AI plc	1,210	-0.12	-0.15	0.00	Renalytix AI EPS beats by $0.06, misses on revenue [6/15/2021 7:10 AM]	32.71	0.96 (3.02%)	31.50	-0.25 (-0.79%)	9.91 - 35.71	77,751	70,000	1,496
Renalytix AI EPS beats by $0.06, misses on revenue [6/15/2021 7:10 AM] Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2021 [Jun-15-21 07:00AM]
02-03-2021	PM		RNLX	Renalytix AI plc	821.14	-0.12	-0.06	0.00	Renalytix AI EPS misses by $0.08, misses on revenue [3/2/2021 1:48 PM]	25.48	-0.35 (-1.36%)	24.10	-1.73 (-6.70%)	9.91 - 29.12	104,986	66,992	4,152
Renalytix AI EPS misses by $0.08, misses on revenue [3/2/2021 1:48 PM] NIH halts a convalescent plasma trial in patients with mild COVID-19 [3/2/2021 1:08 PM] RenalytixAI Reports Financial Results for Second Quarter of Fiscal Year 2021 [Mar-02-21 07:00AM] Renalytix AI Plc - ADR to Host Earnings Call [Mar-02-21 06:30AM]